Home > Media & Technology > Next Generation Technologies > AI and Machine Learning > AI in Predictive Toxicology Market

AI in Predictive Toxicology Market Size

  • Report ID: GMI7363
  • Published Date: Nov 2023
  • Report Format: PDF

AI in Predictive Toxicology Market Size

AI in Predictive Toxicology Market size was valued at USD 281 million in 2022 and is estimated to register a CAGR of over 29.5% between 2023 and 2032. The increasing investments in pharmaceutical AI startups are driving the market growth. These funds enable the development and implementation of advanced technologies, such as Machine Learning (ML) and predictive modeling, to enhance toxicological assessments of chemical compounds

 

For instance, in December 2022, Quris Technologies Ltd., an Israeli pharmaceutical AI startup, gained an extra USD 9 million in seed funding, bringing the total raised amount to USD 37 million. The funding round was spearheaded by SoftBank Vision Fund 2, with contributions from current investors including GlenRock Capital, iAngels, Welltech Ventures, and Richter Group.

Advancements in AI technologies, particularly in ML and deep learning, play a pivotal role in propelling the AI in predictive toxicology market. These technologies enhance the capability to analyze complex data sets, recognize intricate patterns, and generate more accurate predictions regarding the toxicological properties of chemical compounds. The continuous refinement of AI algorithms and the integration of sophisticated computational techniques contribute to the development of robust & reliable models, making AI a key factor in advancing the field of predictive toxicology.

 

The quality and availability of data pose a significant barrier to the AI in predictive toxicology market growth. Inadequate or suboptimal datasets can compromise the training and validation of ML models, potentially leading to inaccurate predictions. Issues, such as data incompleteness, biases, or variability, can undermine the reliability of AI applications. Ensuring access to high-quality, diverse, and representative datasets is crucial for developing robust predictive models in toxicology, but acquiring such data can be a complex and resource-intensive task.

Authors: Preeti Wadhwani

Frequently Asked Questions (FAQ) :

The market size of AI in predictive toxicology reached USD 281 million in 2022 and is set to expand at over 29.5% CAGR from 2023 to 2032, attributed to the increasing investments in pharmaceutical AI startups.

The solution segment accounted for more than 70% of the market share in 2022, owing to the ongoing development of advanced precision medicine and treatment solutions.

North America held more than 44% of the market share in 2022, driven by the robust presence of the pharmaceutical sector in the region.

Some of the leading companies engaged in industry are Benevolent AI, Berg Health, Celsius Therapeutics, Chemaxon Ltd., Insilico Medicine, Instem plc, Lhasa Limited, and, Recursion Pharmaceuticals.

AI in Predictive Toxicology Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 17
  • Tables & Figures: 347
  • Countries covered: 21
  • Pages: 210
 Download Free Sample